191 related articles for article (PubMed ID: 32431666)
1. The Association Between Acylcarnitine Metabolites and Cardiovascular Disease in Chinese Patients With Type 2 Diabetes Mellitus.
Zhao S; Feng XF; Huang T; Luo HH; Chen JX; Zeng J; Gu M; Li J; Sun XY; Sun D; Yang X; Fang ZZ; Cao YF
Front Endocrinol (Lausanne); 2020; 11():212. PubMed ID: 32431666
[No Abstract] [Full Text] [Related]
2. The association and prediction value of acylcarnitine on diabetic nephropathy in Chinese patients with type 2 diabetes mellitus.
Li X; Miao Y; Fang Z; Zhang Q
Diabetol Metab Syndr; 2023 Jun; 15(1):130. PubMed ID: 37330521
[TBL] [Abstract][Full Text] [Related]
3. Acetylcarnitine Is Associated With Cardiovascular Disease Risk in Type 2 Diabetes Mellitus.
Zhao S; Liu ML; Huang B; Zhao FR; Li Y; Cui XT; Lin R
Front Endocrinol (Lausanne); 2021; 12():806819. PubMed ID: 34970228
[TBL] [Abstract][Full Text] [Related]
4. Medium & long-chain acylcarnitine's relation to lipid metabolism as potential predictors for diabetic cardiomyopathy: a metabolomic study.
Zheng DM; An ZN; Ge MH; Wei DZ; Jiang DW; Xing XJ; Shen XL; Liu C
Lipids Health Dis; 2021 Nov; 20(1):151. PubMed ID: 34727932
[TBL] [Abstract][Full Text] [Related]
5. Correlation between Acylcarnitine and Peripheral Neuropathy in Type 2 Diabetes Mellitus.
An Z; Zheng D; Wei D; Jiang D; Xing X; Liu C
J Diabetes Res; 2022; 2022():8115173. PubMed ID: 35224109
[TBL] [Abstract][Full Text] [Related]
6. Low triglyceride as a marker for increased risk of cardiovascular diseases in patients with long-term type 2 diabetes: A cross-sectional survey in China.
Ren Y; Ren Q; Lu J; Guo X; Huo X; Ji L; Yang X
Diabetes Metab Res Rev; 2018 Feb; 34(2):. PubMed ID: 29124871
[TBL] [Abstract][Full Text] [Related]
7. Plasma Acylcarnitines and Risk of Type 2 Diabetes in a Mediterranean Population at High Cardiovascular Risk.
Guasch-Ferré M; Ruiz-Canela M; Li J; Zheng Y; Bulló M; Wang DD; Toledo E; Clish C; Corella D; Estruch R; Ros E; Fitó M; Arós F; Fiol M; Lapetra J; Serra-Majem L; Liang L; Papandreou C; Dennis C; Martínez-González MA; Hu FB; Salas-Salvadó J
J Clin Endocrinol Metab; 2019 May; 104(5):1508-1519. PubMed ID: 30423132
[TBL] [Abstract][Full Text] [Related]
8. Plasma Free Amino Acids and Risk of Cardiovascular Disease in Chinese Patients With Type 2 Diabetes.
Li T; Luo HH; Feng XF; Bai Y; Fang ZZ; Wu GG; Wu JL
Front Endocrinol (Lausanne); 2020; 11():519923. PubMed ID: 33935960
[TBL] [Abstract][Full Text] [Related]
9. Relationship between the plasma acylcarnitine profile and cardiometabolic risk factors in adults diagnosed with cardiovascular diseases.
Kukharenko A; Brito A; Kozhevnikova MV; Moskaleva N; Markin PA; Bochkareva N; Korobkova EO; Belenkov YN; Privalova EV; Larcova EV; Ariani A; La Frano MR; Appolonova SA
Clin Chim Acta; 2020 Aug; 507():250-256. PubMed ID: 32376321
[TBL] [Abstract][Full Text] [Related]
10. The association between plasma free amino acids and type 2 diabetes mellitus complicated with infection in Chinese patients.
Zhang JX; Luo WM; Wang BW; Li RT; Zhang Q; Zhang XY; Fang ZZ; Zhang ZP
Diabetol Metab Syndr; 2024 Jan; 16(1):9. PubMed ID: 38191455
[TBL] [Abstract][Full Text] [Related]
11. Measurement of free carnitine and acylcarnitines in plasma by HILIC-ESI-MS/MS without derivatization.
Peng M; Liu L; Jiang M; Liang C; Zhao X; Cai Y; Sheng H; Ou Z; Luo H
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Aug; 932():12-8. PubMed ID: 23816563
[TBL] [Abstract][Full Text] [Related]
12. Plasma levels of von Willebrand factor in type 2 diabetes patients with and without cardiovascular diseases: A meta-analysis.
Peng X; Wang X; Fan M; Zhao J; Lin L; Liu J
Diabetes Metab Res Rev; 2020 Jan; 36(1):e3193. PubMed ID: 31145835
[TBL] [Abstract][Full Text] [Related]
13. Risks of cardiovascular diseases associated with dipeptidyl peptidase-4 inhibitors and other antidiabetic drugs in patients with type 2 diabetes: a nation-wide longitudinal study.
Ou HT; Chang KC; Li CY; Wu JS
Cardiovasc Diabetol; 2016 Mar; 15():41. PubMed ID: 26932742
[TBL] [Abstract][Full Text] [Related]
14. Associations of Plasma Amino Acid and Acylcarnitine Profiles with Incident Reduced Glomerular Filtration Rate.
Wang F; Sun L; Sun Q; Liang L; Gao X; Li R; Pan A; Li H; Deng Y; Hu FB; Wu J; Zeng R; Lin X
Clin J Am Soc Nephrol; 2018 Apr; 13(4):560-568. PubMed ID: 29519950
[TBL] [Abstract][Full Text] [Related]
15. Identification of Plasma Inositol and Indoxyl Sulfate as Novel Biomarker Candidates for Atherosclerosis in Patients with Type 2 Diabetes. -Findings from Metabolome Analysis Using GC/MS.
Omori K; Katakami N; Arakawa S; Yamamoto Y; Ninomiya H; Takahara M; Matsuoka TA; Tsugawa H; Furuno M; Bamba T; Fukusaki E; Shimomura I
J Atheroscler Thromb; 2020 Oct; 27(10):1053-1067. PubMed ID: 31983701
[TBL] [Abstract][Full Text] [Related]
16. Serum triglycerides as a risk factor for cardiovascular diseases in type 2 diabetes mellitus: a systematic review and meta-analysis of prospective studies.
Ye X; Kong W; Zafar MI; Chen LL
Cardiovasc Diabetol; 2019 Apr; 18(1):48. PubMed ID: 30987625
[TBL] [Abstract][Full Text] [Related]
17. Identification of Metabolites Associated with Onset of CAD in Diabetic Patients Using CE-MS Analysis: A Pilot Study.
Omori K; Katakami N; Yamamoto Y; Ninomiya H; Takahara M; Matsuoka TA; Bamba T; Fukusaki E; Shimomura I
J Atheroscler Thromb; 2019 Mar; 26(3):233-245. PubMed ID: 30068816
[TBL] [Abstract][Full Text] [Related]
18. Interpretable machine learning identifies metabolites associated with glomerular filtration rate in type 2 diabetes patients.
An TF; Zhang ZP; Xue JT; Luo WM; Li Y; Fang ZZ; Zong GW
Front Endocrinol (Lausanne); 2024; 15():1279034. PubMed ID: 38915893
[TBL] [Abstract][Full Text] [Related]
19. Purine Metabolites and Carnitine Biosynthesis Intermediates Are Biomarkers for Incident Type 2 Diabetes.
Ottosson F; Smith E; Gallo W; Fernandez C; Melander O
J Clin Endocrinol Metab; 2019 Oct; 104(10):4921-4930. PubMed ID: 31502646
[TBL] [Abstract][Full Text] [Related]
20. Incidence of cardiovascular events and vascular interventions in patients with type 2 diabetes.
Engelen SE; van der Graaf Y; Stam-Slob MC; Grobbee DE; Cramer MJ; Kappelle LJ; de Borst GJ; Visseren FLJ; Westerink J;
Int J Cardiol; 2017 Dec; 248():301-307. PubMed ID: 28802735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
